[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

@JoseRestonVA Jose Hurtado

Jose Hurtado posts on X about $rna, $apge, $mdgl, $nktr the most. They currently have XXXXX followers and XXX posts still getting attention that total XXXXX engagements in the last XX hours.

Engagements: XXXXX #

X Week XXXXXX -XX%
X Month XXXXXX +49%
X Months XXXXXXX +57%
X Year XXXXXXX +279%

Mentions: XX #

X Week XX -XX%
X Month XXX +12%
X Months XXX +45%
X Year XXX +188%

Followers: XXXXX #

X Week XXXXX +3.30%
X Month XXXXX +17%
X Months XXXXX +63%
X Year XXXXX +94%

CreatorRank: XXXXXXXXX #

Social Influence #

Social category influence stocks XXXX% finance XXXX% cryptocurrencies XXXX% currencies XXXX%

Social topic influence $rna #4, $apge 1.26%, $mdgl #10, $nktr 0.95%, $akro 0.95%, $crvs 0.95%, novartis #22, $novn #8, $zeal #4, $ally #26

Top accounts mentioned or mentioned by @wallstsai @jfais20 @amaymd @monacobiotech @dakotadr2 @bioinvestor24 @seedy19tron @pjamess69 @duedoctor @geneinvesting @krossroads @plainyogurt21 @wassimlaroussi3 @sanctuarybio @stocksgoal20 @sanctuary_bio @persimmonti @maximusholla @andre_agtc @semodough

Top Social Posts #

Top posts by engagements in the last XX hours

"@monaco_biotech In line with what I am seeing this morning with the trajectory of my Swiss names like Novartis $NOVN Roche $ROG Lonza $LONN . So far irrelevance"
X Link @JoseRestonVA 2025-09-26T10:21Z 2897 followers, 1800 engagements

"Opened a small position of Zealand Pharma in the Danish market - $ZEAL"
X Link @JoseRestonVA 2025-10-07T10:41Z 2896 followers, 2971 engagements

"@Maximus_Holla @flutestep @a_a_free I will likely have my $OSCR and $RKT puts worthless (wrong timing) but increasing them everywhere else. So yesstill short financials"
X Link @JoseRestonVA 2025-10-16T17:12Z 2898 followers, XXX engagements

"@sharkbiotech I am actually more interested in (1) which other First Brands are out there and (2) $ALLY (JPM was increasing provision for consumer credit in Q3)"
X Link @JoseRestonVA 2025-10-16T19:45Z 2898 followers, XXX engagements

"Roche has partnership with $ZEAL so I doubt. Novartis $NVS on the other hand could have been interested. Years ago in 2019 they bought The Medicines (Leqvio came out of that acquisition). The $MTSR team comes from The Medicines. I thought that Novartis (long via $NOVN) would have ended up buying them. But no.Pfizer"
X Link @JoseRestonVA 2025-10-07T05:24Z 2897 followers, XXX engagements

"Current biotech position so far Top 5: $MDGL $RNA $IDYA $APGE $MRUS Sizable positions (in that order) $ABVX $MTSR $IMVT Others (in that order) $NKTR $CTMX $AKRO $BHVN $JANX $ORIC $CRVS $ORKA"
X Link @JoseRestonVA 2025-09-16T05:25Z 2886 followers, 8081 engagements

"@alexsgrowth @seedy19tron Interesting article in the FT today about new $GSK CEO Miels and some expectations around bolt-on acquisitions in the future given his style. You might want to check the current pipeline"
X Link @JoseRestonVA 2025-10-12T11:00Z 2896 followers, XXX engagements

"I agree. In biotech at least there is a disconnect between what chart-oriented traders think they see vs. reality. You explained well what is going on with $NVO - there are countless other cases as well. This is a sector where homework to understand what one really owns is required to attempt outsized returns in a consistent manner"
X Link @JoseRestonVA 2025-10-12T18:09Z 2896 followers, 1054 engagements

"As a trade temporarily rotated funds from $NBIX to $RNA"
X Link @JoseRestonVA 2025-08-07T19:59Z 2896 followers, 2025 engagements

"@monaco_biotech @seedy19tron He is entitled to short. Just a few weeks ago he said that $RNA was cooked"
X Link @JoseRestonVA 2025-10-16T20:50Z 2898 followers, XXX engagements

"Added to $RNA (yesterday and today)"
X Link @JoseRestonVA 2025-10-03T16:43Z 2897 followers, 3549 engagements

"Just an observation very respectfully: The fact that he is not coming from a science background is something that I value a lot. Being able to do that learn your way grow and having the success he has hadthat is awesome and should be encouraged. That doesnt mean that he will always be right. No one is. Part of the learning. And we will disagreeover and over. AndI dont come from a science background either unless you consider consumer banking and financial companies like biotechs :)"
X Link @JoseRestonVA 2025-10-17T17:20Z 2898 followers, XX engagements

"@DataDInvesting What started causing this turbulence was First Brands (prior to that Tricolor). To say that because banks are showing good results (so far they are) means that there is no contagion is too much. What I hope is that there are no other First Brands lurking out there"
X Link @JoseRestonVA 2025-10-17T14:59Z 2899 followers, XXX engagements

"Exited $AKRO"
X Link @JoseRestonVA 2025-10-09T10:35Z 2888 followers, 5587 engagements

"@hkuppy I would add $ALLY to that duo"
X Link @JoseRestonVA 2025-10-10T21:35Z 2896 followers, XXX engagements

"@RNAiAnalyst I just wanted to put that money back into CHF asap as I face currency risk if I kept that investment in USD (I feel way more comfortable with the Swiss Franc than with the USD through the year). Also I can rotate that money -if I wanted it- into other options"
X Link @JoseRestonVA 2025-10-11T12:49Z 2896 followers, XXX engagements

"@Maximus_Holla @flutestep @a_a_free Next tweet - still short financials :)"
X Link @JoseRestonVA 2025-10-10T18:02Z 2899 followers, XXX engagements

"Good points on cagri. I am neutral on $NVO in the near term (it should move along with BP names which so far trending up). I liked the $AKRO acquisition as a strategic asset for them as it could give them the chance of a combo to be launched sooner than $MDGL (assuming that both do their GLP1 + MASH asset combo trials and they do well) in addition to the F4c potential but these are more longer-term. Down the road I can reassess (interested to see the comps vs Madrigal - likely a full quarter or 2). MASH TAM is getting bigger than initially thought"
X Link @JoseRestonVA 2025-10-12T18:49Z 2896 followers, XXX engagements

"Whether or not this is a me too or have differentiated assets that become BIC will be determined via readouts next year. My hypothesis is that $APGE is the best of the challengers and therefore allocated funds that way compared to $NKTR $GALD (Galderma - clearly inferior but even they are growing) and $CRVS (there are others of course but those are the ones I am in)But yescertainly with risks. A buy-and-hold-and-manage name for me"
X Link @JoseRestonVA 2025-10-09T09:04Z 2886 followers, XXX engagements

"Updated biotech portfolio after acquisitions additions adjustments and price fluctuations: Top 5: $MDGL $RNA $APGE $ABVX $IDYA Sizable positions: $IMVT $ORKA $ZEAL(Danish market) Others: $QURE $CTMX $OVID $NKTR $BHVN $JANX $ORIC $CRVS I have other positions in the Swiss market some partial hedges and options . Increased cash levels"
X Link @JoseRestonVA 2025-10-13T06:22Z 2898 followers, 11.8K engagements

"@semodough and $APGE too (if you are mentioning those X names)"
X Link @JoseRestonVA 2025-10-11T19:58Z 2896 followers, XXX engagements